Literature DB >> 18973636

Review article: amphetamines and related drugs of abuse.

Shaun L Greene1, Fergus Kerr, George Braitberg.   

Abstract

Acute amphetamine toxicity is a relatively common clinical scenario facing the Australasian emergency medicine physician. Rates of use in Australasia are amongst the highest in the world. Clinical effects are a consequence of peripheral and central adrenergic stimulation producing a sympathomimetic toxidrome and a spectrum of central nervous system effects. Assessment aims to detect the myriad of possible complications related to acute amphetamine exposure and to institute interventions to limit associated morbidity and mortality. Meticulous supportive care aided by judicial use of benzodiazepines forms the cornerstone of management. Beta blockers are contraindicated in managing cardiovascular complications. Agitation and hyperthermia must be treated aggressively. Discharge of non-admitted patients from the emergency department should only occur once physiological parameters and mental state have returned to normal. All patients should receive education regarding the dangers of amphetamine use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973636     DOI: 10.1111/j.1742-6723.2008.01114.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  13 in total

1.  Selective injury of the globus pallidus and hippocampus in methamphetamine-induced encephalopathy.

Authors:  D W Kim; H J Im; J Oh
Journal:  Clin Neuroradiol       Date:  2011-11-24       Impact factor: 3.649

2.  Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations.

Authors:  Haley L Yarosh; Shashwath A Meda; Harriet de Wit; Amy B Hart; Godfrey D Pearlson
Journal:  Psychopharmacology (Berl)       Date:  2015-04-07       Impact factor: 4.530

Review 3.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

4.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Catherine E Sykes; Mrudang M Shah; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2013-01-08       Impact factor: 5.372

Review 5.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

Review 6.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

Review 7.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

8.  Intervention Effect of Repetitive TMS on Behavioral Adjustment After Error Commission in Long-Term Methamphetamine Addicts: Evidence From a Two-Choice Oddball Task.

Authors:  Qiongdan Liang; Jia Lin; Jiemin Yang; Xiang Li; Yijiang Chen; Xianxin Meng; Jiajin Yuan
Journal:  Neurosci Bull       Date:  2018-01-16       Impact factor: 5.203

9.  Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.

Authors:  Takayuki Harada; Hiroshi Tsutomi; Rintaro Mori; David B Wilson
Journal:  Cochrane Database Syst Rev       Date:  2018-12-22

10.  Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012.

Authors:  Szu-Wei Huang; Sheng-Fan Wang; Ángel E Cowó; Marcelo Chen; Yu-Ting Lin; Chun-Po Hung; Yi-Hsien Chen; Jyh-Yuan Yang; Hung-Jen Tang; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.